Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00172159|
Recruitment Status : Unknown
Verified January 2000 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : September 15, 2005
Last Update Posted : June 23, 2010
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Cancer||Procedure: Hepatic resection||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers|
|Study Start Date :||January 2000|
|Estimated Study Completion Date :||June 2005|
- Response rate and resectability after neoadjuvant therapy.
- Survival of the patients.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00172159
|Contact: Jin-Tung Liang, M.D., Ph.||firstname.lastname@example.org|
|Department of Surgery, National Taiwan University Hospital, No.7, Chung-Shan South Road, Taipei, TAIWAN, R.O.C.||Recruiting|
|Taipei, Taiwan, 100|
|Contact: Jin-Tung Liang, M.D., Ph.D. 886-2-23562068|
|Principal Investigator:||Jin-Tung Liang, M.D., Ph.D.||Department of Surgery, National Taiwan University Hospital, No.7, Chung-Shan South Road, Taipei, TAIWAN, R.O.C.|